Suchergebnisse - "Knapper, Steven"

PubPharm (8)

1

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Russell, N. | Wilhelm-Benartzi, C. | Othman, J. | +117

2

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

enthalten in: Leukemia | 2023

von Othman, J. | Potter, N. | Mokretar, K. | +35

3

FLT3 ligand in acute myeloid leukemia : a simple test with deep implications

enthalten in: Leukemia & lymphoma | 2021

von Peterlin, P. | Chevallier, P. | Knapper, S. | +1

4

FLT3 Inhibition in Acute Myeloid Leukaemia - Current Knowledge and Future Prospects

enthalten in: Current cancer drug targets | 2020

von Hogan, F. | Williams, V. | Knapper, S.

5

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

enthalten in: Blood | 2017

von Knapper, S. | Russell, N. | Gilkes, A. | +10

CommentIn: Blood. 2017 Mar 2;129(9):1061-1062. - PMID 28254820

6

The clinical development of FLT3 inhibitors in acute myeloid leukemia

enthalten in: Expert opinion on investigational drugs | 2011

von Knapper, S.

7

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

enthalten in: Blood | 2011

von Sato, T. | Yang, X. | Knapper, S. | +6

CommentIn: Blood. 2011 Mar 24;117(12):3247-8. - PMID 21436074

8

The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts : the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases

enthalten in: Blood | 2006

von Knapper, S. | Mills, K. | Gilkes, A. | +3

1
[1]